Skip to main content
. 2020 May 29;19(2):727–734. doi: 10.1007/s40200-020-00553-w

Table 3.

Prevalence of Sarcopenia according to definition of EWGSOP-1 and EWGSOP-2 by Iranian and European cut- off values in Different Age Groups and gender

EWGSOP V1 (Iranian cutoff) EWGSOP V2 (Iranian cutoff) EWGSOP V2 (European cutoff)
Sarcopenia Severe Sarcopenia Sarcopenia Severe Sarcopenia Sarcopenia Severe Sarcopenia
Men (Years)
60–64

11.80

(8.25–16.15)

2.50

(1.01–5.08)

6.30

(3.80–9.83)

2.50

(1.00-5.01)

7.70

(4.92–11.49)

2.50

(1.00-5.01)

65–69

20.10

(16.40-24.32)

5.00

(3.14–7.59)

10.10

(7.42–13.39)

4.90

(3.08–7.45)

12.30

(9.30-15.77)

5.90

(3.85–8.58)

70–74

20.00

(14.63–26.31)

12.30

(8.04–17.76)

10.00

(6.22–15.02)

12.00

(7.84–17.33)

13.00

(8.67–18.47)

12.50

(8.26–17.90)

≥ 75

27.50

(22.06–33.46)

38.20

(32.21–44.57)

16.30

(11.94–21.42)

38.10

(32.07–44.40)

19.00

(14.39–24.45)

39.30

(33.22–45.61)

Women (Years)
60–64

11.50

(8.15–15.64)

7.90

(5.12–11.52)

4.90

(2.74–7.88)

7.80

(5.04–11.34)

3.20

(1.55–5.85)

3.87

(2.02–6.66)

65–69

16.10

(12.99–19.56)

10.00

(9.13–14.97)

8.30

(6.08–11.04)

9.90

(7.43–12.77)

6.40

(4.43–8.85)

6.60

(4.60–9.07)

70–74

14.80

(9.88–20.89)

25.00

(18.79–32.07)

8.00

(4.42–12.99)

25.00

(18.79–32.07)

6.30

(3.16–10.91)

20.50

(14.76–27.18)

≥ 75

10.00

(6.44–14.62)

37.00

(30.70-43.55)

6.90

(4.01-11.00)

36.80

(30.57–43.37)

5.60

(3.03–9.43)

37.70

(31.40-44.25)

EGWSOP; European Working Group on Sarcopenia in Older People